This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.96% per year. These returns cover a period from January 1, 1988 through October 2, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by FIS.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Sell Stocks for September 21st
by Zacks Equity Research
AIRI, ASB and BCBP have been added to the Zacks Rank #5 (Strong Sell) List on September 21, 2023.
Air Industries (AIRI) Q1 Sales Lag Estimates, Increase Y/Y
by Zacks Equity Research
Air Industries Group's (AIRI) Q1 sales miss the Zacks Consensus Estimate. It faces an increase in interest expenses because of higher loans and a rise in the prime rate.
Air Industries (AIRI) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Air Industries (AIRI) delivered earnings and revenue surprises of -140% and 13.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Leidos (LDOS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Leidos (LDOS) delivered earnings and revenue surprises of 2.58% and 2.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Northrop Grumman (NOC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Northrop Grumman (NOC) delivered earnings and revenue surprises of 0.50% and 3.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lockheed Martin (LMT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Lockheed (LMT) delivered earnings and revenue surprises of 14.37% and 4.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
When Does Market Timing Actually Work? - August 25, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
When Does Market Timing Actually Work? - July 31, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Market Timing Secrets No One Talks About - July 09, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Simple Market Timing Strategies That Work - June 22, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
How to Time the Markets Like an Investing Pro - June 03, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Truth About Market Timing - May 01, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - April 09, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
How to Time the Markets Like an Investing Pro - March 05, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Keys to Successfully Timing the Markets - February 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Air Industries (AIRI) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Air Industries' (AIRI) revenues are likely to have witnessed a boost in the fourth quarter on increased demand for structural parts and components.
Air Industries (AIRI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Air Industries (AIRI) closed at $1.59, marking a +0.63% move from the previous day.
Simple Market Timing Strategies That Work - January 23, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Air Industries (AIRI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Air Industries (AIRI) closed at $2.80 in the latest trading session, marking a +1.82% move from the prior day.
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
Buy Multibagger Stocks as Odds of a Rally Are High in 2020
by Tirthankar Chakraborty
Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.
Lockheed Martin Wins $138M Navy Deal to Support AEGIS CSEA
by Zacks Equity Research
Lockheed Martin's (LMT) AEGIS CSEA is responsible for combat system engineering services, including the design, development and life cycle support, for all AEGIS-equipped ships.
The Market Timing Secrets No One Talks About - January 03, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Lockheed Martin (LMT) Wins $1.93B Deal for F-35 Program
by Zacks Equity Research
Lockheed Martin (LMT), of late, has been witnessing a notable drop in the prices of its F-35 Lightning II Joint Strike Fighter Air Systems.
Lockheed Martin's Unit Wins $40M Deal for Long Range Radar 3
by Zacks Equity Research
Lockheed Martin's (LMT) Long Range Radar 3 program is equipped to protect the U.S. homeland from ballistic missile attacks and increase the effectiveness of ground-based interceptors.